Enhanced papillomavirus-like particle production in insect cells

Virology

Volumn 388, Issue 2, 2009, Pages 344-353

  Senger, Tilo ^a   Schädlich, Lysann ^a   Gissmann, Lutz ^b   Müller, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Assembly; Baculovirus; MultiBac; Papillomavirus; Virus like particle

Indexed keywords

CALGRANULIN; CYSTEINE; MULTIPROTEIN COMPLEX;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE; GENE CASSETTE; GENE EXPRESSION REGULATION; HUMAN PAPILLOMAVIRUS 57; INSECT CELL; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN FOLDING; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS LIKE AGENT; VIRUS RECOMBINANT; WART VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; BIOTECHNOLOGY; CAPSID PROTEINS; CELL LINE; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; INSECTS; PAPILLOMAVIRIDAE; VIRION; VIROLOGY; VIRUS ASSEMBLY; VIRUS REPLICATION;

HEXAPODA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; PAPILLOMAVIRIDAE;

EID: 65549141605     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.04.004     Document Type: Article

References (44)

1. Airenne K.J., Peltomaa E., Hytonen V.P., Laitinen O.H., and Yla-Herttuala S. Improved generation of recombinant baculovirus genomes in Escherichia coli. Nucleic Acids Res. 31 17 (2003) e101
2. Baker T.S., Newcomb W.W., Olson N.H., Cowsert L.M., Olson C., and Brown J.C. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 60 6 (1991) 1445-1456
3. Berger I., Fitzgerald D.J., and Richmond T.J. Baculovirus expression system for heterologous multiprotein complexes. Nat. Biotechnol. 22 12 (2004) 1583-1587
4. Bieniossek, C., Richmond, T. J., and Berger, I. (2008). MultiBac: multigene baculovirus-based eukaryotic protein complex production. Curr Protoc Protein Sci Chapter 5, Unit 5 20.
5. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 4 (2002) 244-265
6. Casini G.L., Graham D., Heine D., Garcea R.L., and Wu D.T. In vitro papillomavirus capsid assembly analyzed by light scattering. Virology 325 2 (2004) 320-327
7. Christensen N.D., Reed C.A., Cladel N.M., Hall K., and Leiserowitz G.S. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 224 2 (1996) 477-486
8. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89 1 (2003) 101-105
9. Cory J.S., and Hails R.S. The ecology and biosafety of baculoviruses. Curr. Opin. Biotechnol. 8 3 (1997) 323-327
10. Cubie H.A., Plumstead M., Zhang W., de Jesus O., Duncan L.A., and Stanley M.A. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls. J. Med. Virol. 56 3 (1998) 210-216
11. DiFalco M.R., Bakopanos E., Patricelli M., Chan G., and Congote L.F. The influence of various insect cell lines, p10 and polyhedrin promoters in the production of secreted insulin-like growth factor-interleukin-3 chimeras in the baculovirus expression system. J. Biotechnol. 56 1 (1997) 49-56
12. Fitzgerald D.J., Berger P., Schaffitzel C., Yamada K., Richmond T.J., and Berger I. Protein complex expression by using multigene baculoviral vectors. Nat. Methods 3 12 (2006) 1021-1032
13. Fitzgerald D.J., Schaffitzel C., Berger P., Wellinger R., Bieniossek C., Richmond T.J., and Berger I. Multiprotein expression strategy for structural biology of eukaryotic complexes. Structure 15 3 (2007) 275-279
14. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., Zahaf T., Innis B., Naud P., De Carvalho N.S., Roteli-Martins C.M., Teixeira J., Blatter M.M., Korn A.P., Quint W., and Dubin G. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 9447 (2004) 1757-1765
15. ® 19 (1997) 6-8
16. Hom L.G., and Volkman L.E. Autographa californica M nucleopolyhedrovirus chiA is required for processing of V-CATH. Virology 277 1 (2000) 178-183
17. Ikonomou L., Schneider Y.J., and Agathos S.N. Insect cell culture for industrial production of recombinant proteins. Appl. Microbiol. Biotechnol. 62 1 (2003) 1-20
18. Kaba S.A., Salcedo A.M., Wafula P.O., Vlak J.M., and van Oers M.M. Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J. Virol. Methods 122 1 (2004) 113-118
19. Kaufmann A.M., Nieland J.D., Jochmus I., Baur S., Friese K., Gabelsberger J., Gieseking F., Gissmann L., Glasschroder B., Grubert T., Hillemanns P., Hopfl R., Ikenberg H., Schwarz J., Karrasch M., Knoll A., Kuppers V., Lechmann M., Lelle R.J., Meissner H., Muller R.T., Pawlita M., Petry K.U., Pilch H., Walek E., and Schneider A. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int. J. Cancer 121 12 (2007) 2794-2800
20. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D.R., and Schiller J.T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67 12 (1993) 6929-6936
21. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 5517 (1975) 495-497
22. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., and Jansen K.U. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347 21 (2002) 1645-1651
23. Li M., Beard P., Estes P.A., Lyon M.K., and Garcea R.L. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J. Virol. 72 3 (1998) 2160-2167
24. Lowy D.R., and Schiller J.T. Prophylactic human papillomavirus vaccines. J. Clin. Invest. 116 5 (2006) 1167-1173
25. Luckow V.A., Lee S.C., Barry G.F., and Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 67 8 (1993) 4566-4579
26. Mao C., Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Wiley D.J., Alvarez F.B., Bautista O.M., Jansen K.U., and Barr E. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet. Gynecol. 107 1 (2006) 18-27
27. Matsuura Y., Possee R.D., Overton H.A., and Bishop D.H. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68 Pt 5 (1987) 1233-1250
28. Muller M., Gissmann L., Cristiano R.J., Sun X.Y., Frazer I.H., Jenson A.B., Alonso A., Zentgraf H., and Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69 2 (1995) 948-954
29. Muller M., Zhou J., Reed T.D., Rittmuller C., Burger A., Gabelsberger J., Braspenning J., and Gissmann L. Chimeric papillomavirus-like particles. Virology 234 1 (1997) 93-111
30. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 6 (2003) 518-527
31. Neeper M.P., Hofmann K.J., and Jansen K.U. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisiae. Gene 180 1-2 (1996) 1-6
32. Possee R.D. Cell-surface expression of influenza virus haemagglutinin in insect cells using a baculovirus vector. Virus. Res. 5 1 (1986) 43-59
33. Roden R.B., Hubbert N.L., Kirnbauer R., Christensen N.D., Lowy D.R., and Schiller J.T. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70 5 (1996) 3298-3301
34. Roelvink P.W., van Meer M.M., de Kort C.A., Possee R.D., Hammock B.D., and Vlak J.M. Dissimilar expression of Autographa californica multiple nucleocapsid nuclear polyhedrosis virus polyhedrin and p10 genes. J. Gen. Virol. 73 Pt 6 (1992) 1481-1489
35. Sapp M., Fligge C., Petzak I., Harris J.R., and Streeck R.E. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J. Virol. 72 7 (1998) 6186-6189
36. Sehr P., Zumbach K., and Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods 253 1-2 (2001) 153-162
37. Slack J.M., Kuzio J., and Faulkner P. Characterization of v-cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus. J. Gen. Virol. 76 Pt 5 (1995) 1091-1098
38. Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., and Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. U.S.A. 92 25 (1995) 11553-11557
39. Suzuki T., Kanaya T., Okazaki H., Ogawa K., Usami A., Watanabe H., Kadono-Okuda K., Yamakawa M., Sato H., Mori H., Takahashi S., and Oda K. Efficient protein production using a Bombyx mori nuclear polyhedrosis virus lacking the cysteine proteinase gene. J. Gen. Virol. 78 Pt 12 (1997) 3073-3080
40. Touze A., El Mehdaoui S., Sizaret P.Y., Mougin C., Munoz N., and Coursaget P. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J. Clin. Microbiol. 36 7 (1998) 2046-2051
41. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R.J., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J., and Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet. Oncol. 6 5 (2005) 271-278
42. Volpers C., Schirmacher P., Streeck R.E., and Sapp M. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200 2 (1994) 504-512
43. Zlotnick A., and Stray S.J. How does your virus grow? Understanding and interfering with virus assembly. Trends. Biotechnol. 21 12 (2003) 536-542
44. zur Hausen H. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111 6 (1999) 581-587